In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Symyx spins off drug company; raises $8mm in Series A financing

Executive Summary

Symyx Technologies (combinatorial technologies, life science, chemical, and electronics applications) has spun off a drug discovery and development company, Symyx Therapeutics Inc., which raised $8mm in its Series A financing through lead investor Sprout Group, and other participant 5am Ventures.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Spin-Off

Related Companies

Advertisement
UsernamePublicRestriction

Register